Rocket Lab valuation risk after strong momentum

Conviction: 72% · Horizon: 1Y · 2026-05-26
Rocket Lab's price may be hard to justify after a large run-up despite continued momentum.

Rocket Lab has delivered major gains, but valuation risk has increased. A potential SpaceX IPO could support investor interest in space stocks, yet it also creates a high-risk catalyst that may amplify volatility.

Instrument Side Target Reason
RKLB Sell The stock's valuation appears stretched after exceptional gains, while momentum and a possible SpaceX IPO create both upside optionality and elevated downside risk. Reducing exposure preserves participation while lowering concentration risk.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.